CH
Collins Helen Louise
OFFICER
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Collins Helen Louise. Insider active across 1 company, notably Enliven Therapeutics, Inc.. Cumulatively, 25 reports have been logged. Breakdown: 0 buy · 14 sells. Total volume traded: €708k. Activity tracked since 11 April 2024. The latest transaction was disclosed on 17 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Collins Helen Louise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
5,000 股@ US$2.480.0003% mcap0.6% 占其流量Common StockSEC:0001701247-26-000012:0
3,900 股@ US$58.37170.0053% mcap11.5% 占其流量Common StockSEC:0001701247-26-000012:1
1,100 股@ US$59.34650.0015% mcap3.3% 占其流量Common StockSEC:0001701247-26-000012:2
63 股@ US$53.92080.0001% mcap0.2% 占其流量Common StockSEC:0001701247-26-000011:5
2,063 股@ US$52.39210.0029% mcap6.5% 占其流量Common StockSEC:0001701247-26-000011:3
5,000 股@ US$2.480.0003% mcap0.7% 占其流量Common StockSEC:0001701247-26-000011:0
231 股@ US$50.05420.0003% mcap0.7% 占其流量Common StockSEC:0001701247-26-000011:1
459 股@ US$51.54660.0006% mcap1.4% 占其流量Common StockSEC:0001701247-26-000011:2
2,184 股@ US$53.41990.0031% mcap7.1% 占其流量Common StockSEC:0001701247-26-000011:4
2,599 股Common StockSEC:0001701247-26-000010:2
5,000 股Common StockSEC:0001701247-26-000010:0
1,268 股Common StockSEC:0001701247-26-000010:1
1,133 股Common StockSEC:0001701247-26-000010:3
140 股@ US$45.81070.0002% mcap1.9% 占其流量Common StockSEC:0001701247-26-000006:1
2,419 股@ US$47.38960.0039% mcap34.3% 占其流量Common StockSEC:0001701247-26-000006:2
2,441 股@ US$48.05550.0040% mcap35.1% 占其流量Common StockSEC:0001701247-26-000006:3
5,000 股@ US$2.480.0004% mcap3.7% 占其流量Common StockSEC:0001701247-26-000006:0
40,000 股@ US$2.4823.2% 占其流量Common StockSEC:0001701247-26-000005:0
5,000 股@ US$2.482.8% 占其流量Common StockSEC:0001701247-26-000004:0
29,871 股@ US$2.4811.9% 占其流量Common StockSEC:0001701247-26-000003:0
45,000 股@ US$2.4817.5% 占其流量Common StockSEC:0001701247-26-000002:0
25,000 股0Common StockSEC:0001701247-26-000001:0
816 股@ US$2.480.7% 占其流量Common StockSEC:0001415889-24-025499:0
816 股@ US$30.0038.0% 占其流量Common StockSEC:0001415889-24-025499:1
20,000 股@ US$2.4816.3% 占其流量Common StockSEC:0001415889-24-010823:0
About Collins Helen Louise
Collins Helen Louise is a declarant linked to Enliven Therapeutics, Inc., where the listed role is CHIEF MEDICAL OFFICER. She has filed 22 filings in total. Across the 22 sampled filings, the recent activity spans 2024-04-15 to 2026-07-21, with 0 EUR of buys and 455006 EUR of sells, and the modal transaction nature is Cession.